Molecular basis for the inhibition of de novo DNA methylation by TCL1A.
Liu, Q., Li, J., Wang, X., Li, Y., Wu, Y., Han, Z., Guo, Z., Guo, L., Wang, X., Yuan, G., Gao, Z., Li, L., Deng, D.(2026) Nat Commun 17
- PubMed: 41786706 Search on PubMedSearch on PubMed Central
- DOI: https://doi.org/10.1038/s41467-025-67710-8
- Primary Citation Related Structures: 
9LQ1 - PubMed Abstract: 
DNA methyltransferases DNMT3A/B mediate de novo DNA methylation, essential for embryonic development and cell fate determination. Dysregulation of DNMT3A/B causes developmental defects and tumorigenesis. TCL1A is critical for embryogenesis but promotes lymphomagenesis when deregulated. Previous studies suggested TCL1A binds DNMT3A/B and inhibits their activity, but the mechanism remained unclear. Here, we report the cryo-EM structure of the DNMT3A-TCL1A complex, which comprises a DNMT3A dimer bound by two TCL1A dimers. TCL1A interacts with the catalytic domain of DNMT3A, overlapping with the DNMT3L-binding site, and induces extended conformational rearrangements. The target recognition domain and catalytic loop shift markedly, reducing DNA accessibility, while the catalytic loop occupies the SAM-binding pocket, thereby blocking methyltransferase activity. Supported by biochemical assays and molecular dynamics simulations, we propose a dynamic inhibition mechanism in which TCL1A exploits DNMT3A conformational plasticity to suppress de novo DNA methylation.
- Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Disease of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, China.
Organizational Affiliation: 

















